Purdue University’s College of Pharmacy and Ohio-based Aprecia Pharmaceuticals LLC are collaborating on future 3-D printed pharmaceutical equipment and medications. Eric Barker, dean of the College of Pharmacy, says the partnership will foster access to 3D printing resources for faculty and students as well as “joint collaborations in research and discovery, learning and teaching, engagement and technical assistance.”
“Purdue University is committed to its investment in drug discovery and development as well as student and faculty enrichment that will continue to yield global advancement in medicine and health care,” Barker said. “As a college, our mission is to prepare the next generation of leaders in pharmacy. Partnering with Aprecia aligns perfectly with that mission. We are excited to combine our talented students and faculty with the successful researchers at Aprecia to work together to accelerate discoveries in this emerging field.”
The university says the partnership aims to advance the technology and science of 3D pharmaceutical printing. Aprecia says it will help lead the initative with its extensive research and experience. The company also developed the first 3D printed medication to receive FDA approval in 2015.
Eric Munson, head of the college’s Department of Industrial and Physical Pharmacy, said that the collaboration will spur the development of advanced medications.
“Giving our faculty and students access to 3DP technology through research projects, internships, and joint collaborations advances our mission of educating and training students through scientific discovery and development,” Munson said. “Incorporating the latest technological developments, like 3DP, into our program are key to producing the best workforce in pharmaceutical formulation and manufacturing.”